Using circulating biomarkers, such as C-reactive protein (CRP) and procalcitonin (PCT), to accurately diagnose, manage and treat infection-induced inflammatory diseases, like sepsis [2] and pneumonia [3], is a highly researched medical field. The gene discussed is CRP; the disease is Sepsis.